JP2020519675A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020519675A5 JP2020519675A5 JP2019563246A JP2019563246A JP2020519675A5 JP 2020519675 A5 JP2020519675 A5 JP 2020519675A5 JP 2019563246 A JP2019563246 A JP 2019563246A JP 2019563246 A JP2019563246 A JP 2019563246A JP 2020519675 A5 JP2020519675 A5 JP 2020519675A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- immunoconjugate
- seq
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023096307A JP2023113921A (ja) | 2017-05-16 | 2023-06-12 | 抗ｆｏｌｒ１イムノコンジュゲートと抗ｐｄ－１抗体の組み合わせ |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762506940P | 2017-05-16 | 2017-05-16 | |
| US62/506,940 | 2017-05-16 | ||
| US201762560462P | 2017-09-19 | 2017-09-19 | |
| US62/560,462 | 2017-09-19 | ||
| US201862647008P | 2018-03-23 | 2018-03-23 | |
| US62/647,008 | 2018-03-23 | ||
| PCT/US2018/032692 WO2018213260A1 (en) | 2017-05-16 | 2018-05-15 | Anti-folr1 immunoconjugates and anti-pd-1 antibody combinations |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023096307A Division JP2023113921A (ja) | 2017-05-16 | 2023-06-12 | 抗ｆｏｌｒ１イムノコンジュゲートと抗ｐｄ－１抗体の組み合わせ |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020519675A JP2020519675A (ja) | 2020-07-02 |
| JP2020519675A5 true JP2020519675A5 (https=) | 2022-05-18 |
Family
ID=64269828
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019563246A Pending JP2020519675A (ja) | 2017-05-16 | 2018-05-15 | 抗ｆｏｌｒ１イムノコンジュゲートと抗ｐｄ−１抗体の組み合わせ |
| JP2023096307A Pending JP2023113921A (ja) | 2017-05-16 | 2023-06-12 | 抗ｆｏｌｒ１イムノコンジュゲートと抗ｐｄ－１抗体の組み合わせ |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023096307A Pending JP2023113921A (ja) | 2017-05-16 | 2023-06-12 | 抗ｆｏｌｒ１イムノコンジュゲートと抗ｐｄ－１抗体の組み合わせ |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US20180333503A1 (https=) |
| EP (1) | EP3625262A4 (https=) |
| JP (2) | JP2020519675A (https=) |
| KR (1) | KR20200006546A (https=) |
| CN (2) | CN118078987A (https=) |
| AU (1) | AU2018269173A1 (https=) |
| BR (1) | BR112019023909A8 (https=) |
| CA (1) | CA3063893A1 (https=) |
| IL (1) | IL314823A (https=) |
| MX (1) | MX2019013753A (https=) |
| RU (1) | RU2019141270A (https=) |
| TW (3) | TW201900221A (https=) |
| WO (1) | WO2018213260A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR122017025062B8 (pt) | 2007-06-18 | 2021-07-27 | Merck Sharp & Dohme | anticorpo monoclonal ou fragmento de anticorpo para o receptor de morte programada humano pd-1, polinucleotídeo e composição compreendendo o referido anticorpo ou fragmento |
| BR112013025415B1 (pt) | 2011-04-01 | 2021-03-16 | Immunogen, Inc | uso de um imunoconjugado antirreceptor de folato 1 (folr1) |
| AU2019236091B2 (en) | 2018-03-13 | 2025-06-05 | Phanes Therapeutics, Inc. | Anti-folate receptor 1 antibodies and uses thereof |
| JP2022500454A (ja) * | 2018-09-17 | 2022-01-04 | ストロ バイオファーマ インコーポレーテッド | 抗葉酸受容体抗体コンジュゲートによる併用療法 |
| CN113574386A (zh) * | 2019-01-03 | 2021-10-29 | 国家医疗保健研究所 | 用于增强癌症患者的cd8+t细胞依赖性免疫应答的方法和药物组合物 |
| BR112023021873A2 (pt) | 2021-04-23 | 2023-12-19 | King S College London | Composição compreendendo um anticorpo ige |
| TW202409080A (zh) * | 2022-07-26 | 2024-03-01 | 美商沙塔克實驗室股份有限公司 | 用於治療卵巢癌之組合療法 |
| CN115960269B (zh) * | 2023-01-30 | 2026-04-03 | 上海甲贝医药科技有限公司 | 一种重组长效人cxcr4&pd-1双靶点抗体融合蛋白及其制备方法 |
| CN120919340A (zh) * | 2024-05-09 | 2025-11-11 | 百奥泰生物制药股份有限公司 | 抗FRα抗体药物偶联物和PD-1拮抗剂在治疗肿瘤中的应用 |
| CN118684782A (zh) * | 2024-07-17 | 2024-09-24 | 武汉科技大学 | 一种muc16和folr1双靶点嵌合抗原受体dcar-16-r1及应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR122017025062B8 (pt) * | 2007-06-18 | 2021-07-27 | Merck Sharp & Dohme | anticorpo monoclonal ou fragmento de anticorpo para o receptor de morte programada humano pd-1, polinucleotídeo e composição compreendendo o referido anticorpo ou fragmento |
| TWI622402B (zh) * | 2010-02-24 | 2018-05-01 | 免疫遺傳股份有限公司 | 葉酸受體１抗體類和免疫共軛物類及彼等之用途 |
| PL2904011T3 (pl) * | 2012-10-02 | 2018-01-31 | Bristol Myers Squibb Co | Połączenie przeciwciał anty-kir i przeciwciał anty-pd-1 w leczeniu raka |
| PL3055332T3 (pl) * | 2013-10-08 | 2020-02-28 | Immunogen, Inc. | Schematy dawkowania immunokoniugatu anty-FOLR1 |
| US20150297744A1 (en) * | 2014-03-28 | 2015-10-22 | Immunogen, Inc. | Anti-FOLR1 Immunoconjugate Dosing Regimens |
| EP4141032B1 (en) * | 2014-11-20 | 2024-05-29 | F. Hoffmann-La Roche AG | Combination therapy of t cell activating bispecific antigen binding molecules and pd-1 axis binding antagonists |
| EP3233918A1 (en) * | 2014-12-19 | 2017-10-25 | Novartis AG | Combination therapies |
| CN116440279B (zh) * | 2015-09-17 | 2026-02-24 | 伊缪诺金公司 | 包含抗folr1免疫缀合物的治疗组合 |
-
2018
- 2018-05-15 US US15/979,989 patent/US20180333503A1/en not_active Abandoned
- 2018-05-15 CA CA3063893A patent/CA3063893A1/en active Pending
- 2018-05-15 AU AU2018269173A patent/AU2018269173A1/en not_active Abandoned
- 2018-05-15 CN CN202410214686.8A patent/CN118078987A/zh active Pending
- 2018-05-15 CN CN201880032356.XA patent/CN110799535A/zh active Pending
- 2018-05-15 EP EP18802195.0A patent/EP3625262A4/en not_active Withdrawn
- 2018-05-15 KR KR1020197034686A patent/KR20200006546A/ko not_active Ceased
- 2018-05-15 RU RU2019141270A patent/RU2019141270A/ru unknown
- 2018-05-15 WO PCT/US2018/032692 patent/WO2018213260A1/en not_active Ceased
- 2018-05-15 JP JP2019563246A patent/JP2020519675A/ja active Pending
- 2018-05-15 MX MX2019013753A patent/MX2019013753A/es unknown
- 2018-05-15 IL IL314823A patent/IL314823A/en unknown
- 2018-05-15 BR BR112019023909A patent/BR112019023909A8/pt unknown
- 2018-05-16 TW TW107116641A patent/TW201900221A/zh unknown
- 2018-05-16 TW TW111134010A patent/TW202322853A/zh unknown
- 2018-05-16 TW TW113100663A patent/TW202440170A/zh unknown
-
2021
- 2021-07-21 US US17/382,286 patent/US20220160889A1/en not_active Abandoned
-
2023
- 2023-06-12 JP JP2023096307A patent/JP2023113921A/ja active Pending
- 2023-10-18 US US18/489,292 patent/US20240299571A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020519675A5 (https=) | ||
| JP6800853B2 (ja) | 抗ｃ１０ｏｒｆ５４抗体およびその使用 | |
| TWI912619B (zh) | 使用抗ｐｄ-１抗體與抗ｃｔｌａ-４抗體之組合以治療肺癌 | |
| JP2025129187A5 (https=) | ||
| US12246025B2 (en) | Methods of treating cancer with a combination of a platinum-based agent and an anti-tissue factor antibody-drug conjugate | |
| CN115485304B (zh) | 抗体药物偶联物及其制剂 | |
| US12324841B2 (en) | Methods of treating cancer with a combination of an anti-PD-1 antibody and an anti-tissue factor antibody-drug conjugate | |
| CN117222663A (zh) | 使用结合nkg2d、cd16和肿瘤相关抗原的多特异性结合蛋白治疗癌症的方法 | |
| RU2019141270A (ru) | Комбинации анти-folr1 иммуноконъюгатов и анти-pd-1 антител | |
| CN110475569A (zh) | 通过施用抗her3抗体-药物偶联物实现的egfr-tki耐受性的非小细胞肺癌的治疗方法 | |
| US20210030888A1 (en) | Anti-tissue factor antibody-drug conjugates and their use in the treatment of cancer | |
| CA3118542A1 (en) | Cdcp1-targeted therapies | |
| CA3080137A1 (en) | Anti-tissue factor antibody-drug conjugates and their use in the treatment of cancer | |
| WO2018072743A1 (zh) | Pd-1抗体与ido抑制剂联合在制备抗肿瘤的药物中的用途 | |
| TW202207976A (zh) | 使用免疫檢查點抑制劑抗體治療癌症之方法和組合 | |
| WO2024026019A1 (en) | Methods for treating chronic myelomonocytic leukemia with anti-ilt3 antibodies | |
| WO2023174408A1 (zh) | 抗tim-3抗体与抗pd-l1抗体的药物组合 | |
| JP2019505516A (ja) | インターロイキン−１７（ｉｌ−１７）アンタゴニストを使用してざ瘡を治療する方法 | |
| WO2026092660A1 (zh) | 抗her2抗体药物偶联物和抗pd-l1抗体联合在制备治疗乳腺癌的药物中的用途 | |
| HK40084048B (zh) | 抗体药物偶联物及其制剂 | |
| WO2026021442A1 (zh) | 抗体药物偶联物在制备治疗肺癌的药物中的用途 | |
| WO2025190318A1 (zh) | 抗her2抗体药物偶联物和her二聚化抑制剂联合治疗实体瘤 | |
| WO2025256641A1 (zh) | 抗pd-l1抗体和抗ctla-4抗体联合治疗肿瘤 | |
| CN115611981A (zh) | 抗pd-1抗体在治疗外周t细胞淋巴瘤中的应用 | |
| CN115607663A (zh) | 抗pd-1抗体在治疗原发纵隔大b细胞淋巴瘤中的应用 |